Peer-reviewedCC BYCancer innovation
Molecular Mechanisms and Therapeutic Advances in KRAS G12C‐Mutant Non‐Small Cell Lung Cancer: Toward Mechanism‐Guided Longitudinal Management
- 1Peking University Cancer Hospital
Related
- Lactylation in liver fibrosis: from molecular mechanisms to targeted therapeutic strategies
- Molecular mechanisms for sustaining cancer stem cells characteristics and targeted therapeutic strategies
- Myocardial Ischemia-Reperfusion Injury: Molecular Mechanisms and Innovative Therapeutic Strategies
- Dexmedetomidine as a potential neuroprotective agent against Alzheimer’s disease: molecular mechanisms and therapeutic perspectives
- Recent advances in Alzheimer’s disease: From molecular mechanisms to therapeutic strategies
BibTeX
@article{wang2026molecular,
title = {{Molecular Mechanisms and Therapeutic Advances in KRAS G12C‐Mutant Non‐Small Cell Lung Cancer: Toward Mechanism‐Guided Longitudinal Management}},
author = {Haiying Wang and Hanxiao Chen and Sheng Li and Jun Zhao},
journal = {Cancer innovation},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13673135},
note = {CC BY},
}
RIS
TY - JOUR
TI - Molecular Mechanisms and Therapeutic Advances in KRAS G12C‐Mutant Non‐Small Cell Lung Cancer: Toward Mechanism‐Guided Longitudinal Management
AU - Haiying Wang
AU - Hanxiao Chen
AU - Sheng Li
AU - Jun Zhao
PY - 2026
DA - 2026/10/01
JO - Cancer innovation
UR - https://europepmc.org/article/PMC/PMC13673135
SN - 2770-9191
SN - 2770-9183
ER -